Ajanta Pharma informs about written transcript of earnings call

Ajanta Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532331 | NSE: AJANTPHARM

05 May 2025 Evaluate

Further to communication dated 30th April 2025 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ajanta Pharma has informed that written transcript of the earnings call held on 30th April 2025 at 4.30 pm has been uploaded on the Company’s website and can be accessed through the link https://ajantapharma.com//images/Earnings-Call-Transcript-Q4-(Jan-Mar)-2024-25.pdf.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1858.00
Dr. Reddys Labs.	1170.50
Cipla	1377.85
Lupin	2082.00
Zydus Lifesciences	1136.70
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.